// AST – IMS - [DMinute_ROS]

Private Advisor Group Boosted Advanced Micro Devices (AMD) Stake by $518,790; Market Valuation Declined; Rock Springs Capital Management LP Has Decreased Position in Alexion Pharmaceuticals (ALXN) by $26.76 Million

Advanced Micro Devices, Inc. (NASDAQ:AMD) Logo

Rock Springs Capital Management Lp decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 39.09% based on its latest 2018Q3 regulatory filing with the SEC. Rock Springs Capital Management Lp sold 192,500 shares as the company’s stock declined 2.68% with the market. The hedge fund held 300,000 shares of the health care company at the end of 2018Q3, valued at $41.70M, down from 492,500 at the end of the previous reported quarter. Rock Springs Capital Management Lp who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be less bullish one the $24.48B market cap company. The stock decreased 1.25% or $1.38 during the last trading session, reaching $109.75. About 470,678 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 7.37% since January 14, 2018 and is uptrending. It has outperformed by 7.37% the S&P500. Some Historical ALXN News: 11/04/2018 – From the dawn patrol — Alexion takes its first step rebuilding the pipeline, adding a rare disease drug in $855M cash buyout $ALXN; 12/04/2018 – ALEXION PHARMACEUTICALS INC ALXN.O : NOMURA RAISES TARGET PRICE TO $165 FROM $156; 26/04/2018 – Alexion Pharmaceuticals 1Q Adj EPS $1.68; 20/04/2018 – ALEXION PHARMACEUTICALS – ALEXION WOULD LIKE TO CLARIFY THAT NO COMPULSORY LICENSE OF SOLIRIS WAS REQUESTED OR GRANTED IN BRAZIL; 20/04/2018 – Alexion Provides Statement on Superior Court of Justice (STJ) Decision in Brazil Involving Soliris® (Eculizumab); 16/04/2018 – APELLIS – IN H2 2018, PLANS TO INITIATE A PHASE 3 TRIAL IN 70 PATIENTS WITH PNH VS TREATMENT WITH APL-2 MONOTHERAPY TO TREATMENT WITH ECULIZUMAB; 11/04/2018 – Alexion Will Acquire Wilson Through a Tender OfferWhereby Alexion, Through Subsidiary, Has Offered SEK232 in Cash for Each Outstanding Share of Wilson; 27/04/2018 – Alexion preps an FDA pitch on Soliris successor while signaling more deals ahead for rare disease drugs $ALXN; 23/04/2018 – Alexion Pharmaceuticals Inc expected to post earnings of $1.50 a share – Earnings Preview; 20/04/2018 – Alexion: Brazil Patent Issue Has No Implications for Intellectual Property Outside Brazil

Private Advisor Group Llc increased its stake in Advanced Micro Devices Inc (AMD) by 116.79% based on its latest 2018Q3 regulatory filing with the SEC. Private Advisor Group Llc bought 17,293 shares as the company’s stock declined 33.12% with the market. The institutional investor held 32,100 shares of the technology company at the end of 2018Q3, valued at $992,000, up from 14,807 at the end of the previous reported quarter. Private Advisor Group Llc who had been investing in Advanced Micro Devices Inc for a number of months, seems to be bullish on the $20.45 billion market cap company. The stock increased 0.96% or $0.19 during the last trading session, reaching $20.46. About 36.00M shares traded. Advanced Micro Devices, Inc. (NASDAQ:AMD) has risen 99.10% since January 14, 2018 and is uptrending. It has outperformed by 99.10% the S&P500. Some Historical AMD News: 16/03/2018 – Fudzilla: AMD Ryzen 5 2600X shows up briefly on Amazon.de; 13/03/2018 – Pixium Vision Announces Successful Activations with PRIMA, Its Breakthrough Bionic Vision System, in the First Three Patients with Atrophic Dry-AMD; 16/03/2018 – S&PGR Upgrades Advanced Micro Devices To ‘B’; Outlook Stable; 03/04/2018 – AMD Adds Yahoo Japan to a Growing List of Internet Service Providers Seizing on the Performance and Scalability of the AMD EPYC; 25/04/2018 – Advanced Micro Devices Sees 2Q Rev $1.725B, Plus or Minus $50M; 16/05/2018 – Tech Today: AMD’s Window of Opportunity, Spotify’s Churn, Defending AMAT — Barron’s Blog; 27/03/2018 – ClinicalTrial US: Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD; 13/03/2018 – ADVANCED MICRO DEVICES – INVESTIGATING CTS LABS REPORT, WHICH CO GOT, TO UNDERSTAND METHODOLOGY & MERIT OF FINDINGS; 21/04/2018 – DJ Advanced Micro Devices Inc, Inst Holders, 1Q 2018 (AMD); 29/05/2018 – Tech Report: Rumor: Dual-core AMD Athlon 200GE and Athlon Pro 200GE on the way

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 24 have Buy rating, 0 Sell and 5 Hold. Therefore 83% are positive. Alexion Pharmaceuticals Inc. had 118 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Citigroup on Monday, June 27. The rating was maintained by RBC Capital Markets on Friday, February 17 with “Outperform”. Stifel Nicolaus maintained the shares of ALXN in report on Tuesday, September 12 with “Buy” rating. The company was downgraded on Tuesday, December 13 by Morgan Stanley. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Leerink Swann on Wednesday, September 13. Leerink Swann maintained the shares of ALXN in report on Wednesday, December 6 with “Buy” rating. FBR Capital upgraded Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) rating on Friday, October 28. FBR Capital has “Mkt Perform” rating and $130 target. The company was maintained on Friday, February 9 by Deutsche Bank. The stock has “Buy” rating by Morgan Stanley on Friday, July 28. Barclays Capital maintained it with “Equal-Weight” rating and $175 target in Thursday, February 4 report.

More notable recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: Nasdaq.com which released: “Acorda Gets FDA Approval for Parkinson’s Disease Drug Inbrija – Nasdaq” on December 24, 2018, also Nasdaq.com with their article: “February 2019 Options Now Available For Alexion Pharmaceuticals (ALXN) – Nasdaq” published on December 27, 2018, Nasdaq.com published: “Here’s Why Alexion Pharmaceuticals Is Surging Today – Nasdaq” on April 26, 2018. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) were released by: Seekingalpha.com and their article: “Alexion: Priced Right For Long-Term Investors – Seeking Alpha” published on August 16, 2018 as well as Nasdaq.com‘s news article titled: “Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 6,332.99 – Nasdaq” with publication date: December 21, 2018.

Investors sentiment decreased to 1.04 in 2018 Q3. Its down 0.16, from 1.2 in 2018Q2. It dived, as 51 investors sold ALXN shares while 168 reduced holdings. 66 funds opened positions while 161 raised stakes. 203.25 million shares or 0.19% less from 203.64 million shares in 2018Q2 were reported. Loomis Sayles & Co Limited Partnership has 36,717 shares. Brinker Cap has 7,582 shares for 0.04% of their portfolio. Asset Management holds 0.04% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 19,670 shares. Walleye Trading Limited Liability Corp reported 0.01% stake. Northern Tru Corporation has invested 0.1% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). American Century owns 1.90M shares. Ameritas Investment Ptnrs Inc holds 0.05% or 7,927 shares. Bnp Paribas Arbitrage has 165,868 shares for 0% of their portfolio. Hills National Bank & Trust Tru invested in 7,744 shares or 0.29% of the stock. Signaturefd Limited Liability owns 547 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.06% or 51,549 shares in its portfolio. Moreover, Creative Planning has 0.01% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Canada Pension Plan Invest Board holds 320,637 shares or 0.08% of its portfolio. Amalgamated Bancorporation holds 0.11% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 31,549 shares. Deutsche Bank Ag invested in 0.1% or 1.01 million shares.

Rock Springs Capital Management Lp, which manages about $319.00M and $2.76B US Long portfolio, upped its stake in Biocryst Pharmaceuticals (NASDAQ:BCRX) by 450,000 shares to 700,000 shares, valued at $5.34M in 2018Q3, according to the filing. It also increased its holding in Radius Health Inc (NASDAQ:RDUS) by 142,500 shares in the quarter, for a total of 1.27 million shares, and has risen its stake in Edwards Lifesciences Corp (NYSE:EW).

Since November 28, 2018, it had 0 insider buys, and 2 sales for $618,666 activity. Shares for $310,937 were sold by HANTSON LUDWIG on Monday, December 31.

Analysts await Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report earnings on February, 14. They expect $1.61 earnings per share, up 25.78% or $0.33 from last year’s $1.28 per share. ALXN’s profit will be $359.17 million for 17.04 P/E if the $1.61 EPS becomes a reality. After $1.86 actual earnings per share reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -13.44% negative EPS growth.

More notable recent Advanced Micro Devices, Inc. (NASDAQ:AMD) news were published by: Nasdaq.com which released: “AMD Stock Looks Good Ahead of Q3 Earnings Report – Nasdaq” on October 24, 2018, also Nasdaq.com with their article: “Pre-Market Most Active for Jan 4, 2019 : QQQ, SQQQ, AMD, TQQQ, AAPL, GE, BOTZ, CHK, NOK, BBVA, VALE, BABA – Nasdaq” published on January 04, 2019, Seekingalpha.com published: “Tough quarter leaves semis in the red – Seeking Alpha” on December 31, 2018. More interesting news about Advanced Micro Devices, Inc. (NASDAQ:AMD) were released by: Nasdaq.com and their article: “AMD Stock Continues to Slide Following Intel Report – Nasdaq” published on October 03, 2018 as well as Nasdaq.com‘s news article titled: “Here’s Why AMD Stock Is Gaining Again Today – Nasdaq” with publication date: September 13, 2018.

Since July 16, 2018, it had 0 buys, and 26 selling transactions for $498.87 million activity. 175,553 shares valued at $3.81 million were sold by Su Lisa T on Wednesday, November 7. ANDERSON JAMES ROBERT sold 150,000 shares worth $3.06 million. 70,000 shares were sold by Papermaster Mark D, worth $1.16 million on Monday, July 16. Norrod Forrest Eugene had sold 62,500 shares worth $2.03M. 133,420 shares were sold by WOLIN HARRY A, worth $2.60 million. $425.15M worth of Advanced Micro Devices, Inc. (NASDAQ:AMD) was sold by Mubadala Investment Co PJSC.

Private Advisor Group Llc, which manages about $5.58 billion and $4.88B US Long portfolio, decreased its stake in Bank New York Mellon Corp (NYSE:BK) by 6,333 shares to 48,323 shares, valued at $2.46M in 2018Q3, according to the filing. It also reduced its holding in Abm Inds Inc (NYSE:ABM) by 85,025 shares in the quarter, leaving it with 21,725 shares, and cut its stake in Royal Caribbean Cruises Ltd (NYSE:RCL).

Among 35 analysts covering Advanced Micro (NASDAQ:AMD), 12 have Buy rating, 2 Sell and 21 Hold. Therefore 34% are positive. Advanced Micro had 152 analyst reports since August 13, 2015 according to SRatingsIntel. On Wednesday, October 25 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm has “Hold” rating given on Wednesday, July 19 by M Partners. Robert W. Baird maintained Advanced Micro Devices, Inc. (NASDAQ:AMD) on Monday, June 4 with “Buy” rating. The rating was maintained by Stifel Nicolaus on Thursday, July 20 with “Hold”. The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) has “Hold” rating given on Monday, October 16 by BMO Capital Markets. The firm has “Hold” rating given on Tuesday, June 26 by Benchmark. The rating was upgraded by Vetr on Tuesday, September 22 to “Strong-Buy”. BMO Capital Markets maintained the shares of AMD in report on Sunday, April 8 with “Hold” rating. Northland Capital maintained the stock with “Buy” rating in Monday, March 5 report. The firm has “Underweight” rating given on Monday, October 30 by Morgan Stanley.

Investors sentiment increased to 1.45 in Q3 2018. Its up 0.22, from 1.23 in 2018Q2. It improved, as 45 investors sold AMD shares while 130 reduced holdings. 121 funds opened positions while 132 raised stakes. 561.76 million shares or 7.07% less from 604.47 million shares in 2018Q2 were reported. Sigma Planning holds 0.07% or 38,775 shares in its portfolio. Alliancebernstein Limited Partnership holds 5.36M shares or 0.11% of its portfolio. 110,344 were reported by Norinchukin National Bank & Trust The. Amundi Pioneer Asset invested in 2.53 million shares or 0.1% of the stock. Quantres Asset Ltd accumulated 52,400 shares. Natixis Advisors Lp accumulated 35,213 shares. Blair William & Il reported 15,128 shares stake. Liberty Mutual Grp Inc Asset owns 32,935 shares or 0.02% of their US portfolio. Mutual Of America Capital Management Ltd Limited Liability Company has 111,050 shares. Ims Capital Mngmt reported 32,185 shares. Bnp Paribas Asset Mngmt Hldgs reported 0.25% in Advanced Micro Devices, Inc. (NASDAQ:AMD). Moreover, Hightower Advisors Limited Liability Company has 0.01% invested in Advanced Micro Devices, Inc. (NASDAQ:AMD). Thrivent Fincl For Lutherans has 1.62 million shares for 0.16% of their portfolio. Mirae Asset Global Investments Limited has 0.04% invested in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 169,830 shares. Castleark Mngmt Limited Co holds 0.14% or 152,250 shares.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.